Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial

Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenthal, James A., Smith, Patrick J., Jiang, Wei, Hinderliter, Alan, Watkins, Lana L., Hoffman, Benson M., Kraus, William E., Mabe, Stephanie, Liao, Lawrence, Davidson, Jonathan, Sherwood, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604196/
https://www.ncbi.nlm.nih.gov/pubmed/36286272
http://dx.doi.org/10.3390/jcdd9100320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604196/
https://www.ncbi.nlm.nih.gov/pubmed/36286272
http://dx.doi.org/10.3390/jcdd9100320

Ejemplares similares